drugset / Trial / NCT04841499

Effects of a Seven-day BASIS™ Supplementation on Menopausal Syndromes and Measurements of the Urinary Vitamin B3 and Estradiol Levels in Pre-, Peri- and Post-menopause

NCT04841499

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether a short supplementation (7days) with BASIS™ increases the natural production of estradiol, measured in urinary waste. The overall objective is to determine whether through increased estradiol levels, the undesirable menopausal effects, assessed via questionnaires, are mitigated by a short-term supplementation with BASIS™

Timeline

Start
2021-04-05
Primary completion
2021-07-15
Completion
2021-07-15

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Nicotinamide riboside Small molecule 250 mg Oral
Subject Pterostilbene Small molecule 50 mg Oral

Indications

No indication recorded.